CDH1 and meningioma: Through analysis of the differential expression of E-Cadherin across the different World Health Organization (WHO) histopathological subgroups of meningiomas, it was found that aggressive WHO II meningiomas involve a loss of E-Cadherin and related Zo-1 compared to WHO I meningiomas.